"If we could have more clinical or educational programs that teach...
Category:
Health
Latest
Need for state-specific policies to seize rapidly rising epidemic of metabolic non-communicable diseases: ICMR study
According to the study published in The Lancet, the prevalence of...
Ensure availability of critical health services in flood-affected Assam: Mandaviya to officials
Union Health Minister Mansukh Mandaviya directed them to prepare an...
Private sector willing to partner with govt for accelerating COVID-19 vaccine administration: FICCI
Private healthcare sector, responsible for almost 70 per cent of healthcare delivery in the country, can adequately supplement the physical and human infrastructure supply in key capacity constrained regions, specifically in urban and semi-urban areas, FICCI noted.
COVID recoveries cross 1 cr-mark; recovered cases are 44 times number of active cases
The national COVID-19 recovery rate stands at 96.36 percent. Following the national pursuit, all states and union territories have recovery rate more than 90 percent.
“India’s recovery rate is the highest in the world. Countries with higher caseload are reporting lesser recovery rate than India’s,” the ministry underlined.
With the expansion in the testing infrastructure, the COVID-19 positivity rate of India has also gone down. The daily positivity rate remains below 3 per cent.
Who’s on the hook if Covid -19 vaccines go wrong?
Adar Poonawalla, the chief executive of Serum Institute of India Ltd., the world’s largest vaccine maker by volume, wants indemnity. Competitors tripping up one another by instigating frivolous civil suits isn’t a trivial risk for the likes of Poonawalla, who’s manufacturing the jab developed by AstraZeneca Plc and Oxford University.
Covid-19 vaccines 110% safe, impotency rumours complete nonsense: DCGI
When asked if people would face side effects after taking the vaccine, the DCGI said, “Yes, minor side effects will be there, including a little like pain in the shoulders, a slight fever, little allergies. This occurs in every vaccine but of-course, the vaccine is 110 per cent safe.”
Private investigators’ body APDI forms global alliance against fake Covid-19 vaccines
APDI Chairman Kunwar Vikram Singh in a statement said, “The GAFV has been formed after reports emanating from several countries about the circulation of fake Covid vaccines. Already, Europol, the European Union’s law enforcement agency, has issued a warning of fake vaccine circulation due to huge demands.”
WHO calls for intensified measures over ‘alarming’ virus variant
“This is an alarming situation, which means that for a short period of time we need to do more than we have done and to intensify the public health and social measures to be certain we can flatten the steep vertical line in some countries,” WHO’s regional director for Europe Hans Kluge, said, referring primarily to the new variant first discovered in the UK.
4,400 adverse events reported in US after receiving Pfizer-BioNTech vaccine
Locations administering Covid-19 vaccines should adhere to CDC guidance for use of the jabs, including screening recipients for contraindications and precautions, having the necessary supplies available to manage anaphylaxis, implementing the recommended post-vaccination observation periods, and immediately treating suspected cases of anaphylaxis with an intramuscular injection of epinephrine, said the CDC
Centre ready to pay vaccination cost in 1st phase: Maharashtra health minister Rajesh Tope
“We are going to set up vaccination centres at state and civic-run hospitals. If we could set up 100 such centres with each catering to 100 persons, we can cover the entire health staff in 70 to 80 days,” the minister said.
Moderna CEO says vaccine likely to protect for ‘couple of years’
“The nightmare scenario that was described in the media in the spring with a vaccine only working a month or two is, I think, out of the window.The antibody decay generated by the vaccine in humans goes down very slowly (…) We believe there will be protection potentially for a couple of years,” Moderna CEO Stephane Bancel said
Pfizer/BioNTech vaccine appears effective against mutation in new coronavirus variants -study
The Pfizer/BioNTech vaccine and the one from Moderna Inc, which use synthetic messenger RNA technology, can be quickly tweaked to address new mutations of a virus if necessary. Scientists have suggested the changes could be made in as little as six weeks.